TGA
TGA takes RAT action
Federal Court proceedings have been initiated over the alleged importation and supply of unapproved Covid-19 RATs Queensland-based company, Key Promotional Products Pty Ltd (KPP) and the husband of the firm’s …
Vyvanse shortages return
Less than two months after the TGA declared shortages of Vyvanse to be “resolved” the regulator is now reporting the medication is once again in short supply The Therapeutic Goods …
Suspended sentence for Therapeutic Goods Act breaches
Business owner handed a two-year suspended sentence for his role in the unlawful manufacture, supply and export of performance and image-enhancing drugs Businessman, Ryan Gregory McTeigue, has avoided time behind …
Zactin Tabs shortage set to continue
TGA extends fluoxetine substitution instrument in response to ongoing manufacturing issues Supply shortages impacting Zactin Tabs (fluoxetine 20mg dispersible tablets) are expected to continue until 30 June 2024, the medication’s …
Pharmacy fined over Ozempic advertising
Western Sydney pharmacy hit with a fine of more than $18,000 in relation to alleged unlawful advertising of Ozempic The Therapeutic Goods Administration (TGA) has issued an infringement notice of $18,780 …
No change to paracetamol
TGA rules out a general sale option for small effervescent, child resistant, paracetamol packs The Therapeutic Goods Administration (TGA) has confirmed a preliminary decision to reject a proposal to allow …
New sexual dysfunction warnings added to antidepressants’ PI
Health professionals are advised to consider current or previous antidepressant use in patients reporting sexual dysfunction Updated product information documents (PIs) for nine antidepressant medications will include warnings relating to …
TGA continues cannabis advertising clampdown
Regulator targets medicinal cannabis pharmacy over alleged unlawful advertising The Therapeutic Goods Administration (TGA) has issued nine infringement notices totalling $164,460 to Victorian pharmacy, Better Leaf Pty Ltd, over alleged unlawful …
Government acts on compounding concerns
Compounding exemptions for diabetes medications, Ozempic and Mounjaro, will be removed from 1 October, minister reveals Compounding pharmacies will be barred from producing replicas of Ozempic (semaglutide) and Mounjaro (tirazapetide) …
TGA issues SSSI for abatacept
Pharmacists authorised to substitute Orencia 125mg/mL products to deal with shortages The Therapeutic Goods Administration (TGA) has issued a Serious Scarcity Substitution Instrument (SSSI) in response to shortages of both …
GSK to bolster Shingrix supply
TGA grants temporary approval for the use of overseas-sourced Shingrix in Australia GSK is set to supply Shingrix vaccines registered in Hong Kong to the Australian market for patients eligible …
Abatacept shortage hits earlier than forecast
Pharmacists urged to advise patients with prescriptions for Orencia (abatacept) to speak to their specialists as shortages hit Bristol-Myers Squibb Australia (BMS) has advised the Therapeutic Goods Administration (TGA) that …